Vivek Ramaswamy's Wealth Linked to Roivant Sciences' Biotech Value
What happened
Forbes reported that Vivek Ramaswamy's personal wealth was largely built through business ownership, specifically his stake in Roivant Sciences. Ramaswamy founded Roivant Sciences in 2014, a company that develops medicines for conditions including cancer and inflammatory diseases. In 2020, Sumitomo Dainippon Pharma acquired interests in five Roivant subsidiaries for $3 billion, taking a 10% stake in the company.
From indiatimes.com
Why it matters
The report highlights the financial value generated by Roivant Sciences' operations, which went public in 2021 at a valuation of approximately $7.3 billion. This financial performance has been the biggest factor in building Vivek Ramaswamy's fortune.
From indiatimes.com
Who's involved
- Vivek RamaswamyFounder of Roivant Sciences and subject of the financial report
- Roivant Sciences (United States)Biotechnology company whose performance shaped Vivek Ramaswamy's wealth
- ForbesAmerican business magazine that published the report on the financial stake
Keep exploring
The entities involved
-
Vivek Ramaswamy
American presidential candidate and businessman (born 1985)
-
Roivant Sciences (United States)
company in New York, United States
-
Forbes
American business magazine